Ortivus AB ser. A (ORTI-A) - Net Assets
Based on the latest financial reports, Ortivus AB ser. A (ORTI-A) has net assets worth Skr22.41 Million SEK (≈ $2.41 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr70.93 Million ≈ $7.63 Million USD) and total liabilities (Skr48.52 Million ≈ $5.22 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Ortivus AB ser. A's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr22.41 Million |
| % of Total Assets | 31.6% |
| Annual Growth Rate | -9.95% |
| 5-Year Change | -23.88% |
| 10-Year Change | 329.22% |
| Growth Volatility | 95.23 |
Ortivus AB ser. A - Net Assets Trend (2003–2025)
This chart illustrates how Ortivus AB ser. A's net assets have evolved over time, based on quarterly financial data. Also explore ORTI-A total asset value for the complete picture of this company's asset base.
Annual Net Assets for Ortivus AB ser. A (2003–2025)
The table below shows the annual net assets of Ortivus AB ser. A from 2003 to 2025. For live valuation and market cap data, see how much is Ortivus AB ser. A worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr22.41 Million ≈ $2.41 Million |
+412.83% |
| 2024-12-31 | Skr-7.17 Million ≈ $-771.07K |
-141.40% |
| 2023-12-31 | Skr17.30 Million ≈ $1.86 Million |
-51.16% |
| 2022-12-31 | Skr35.44 Million ≈ $3.81 Million |
+20.35% |
| 2021-12-31 | Skr29.44 Million ≈ $3.17 Million |
+49.63% |
| 2020-12-31 | Skr19.68 Million ≈ $2.12 Million |
+124.79% |
| 2019-12-31 | Skr8.75 Million ≈ $942.07K |
+301.38% |
| 2018-12-31 | Skr2.18 Million ≈ $234.71K |
-85.98% |
| 2017-12-31 | Skr15.55 Million ≈ $1.67 Million |
+197.87% |
| 2016-12-31 | Skr5.22 Million ≈ $561.97K |
-57.76% |
| 2015-12-31 | Skr12.36 Million ≈ $1.33 Million |
-36.10% |
| 2014-12-31 | Skr19.35 Million ≈ $2.08 Million |
+12.41% |
| 2013-12-31 | Skr17.21 Million ≈ $1.85 Million |
-44.81% |
| 2012-12-31 | Skr31.19 Million ≈ $3.36 Million |
+7.43% |
| 2011-12-31 | Skr29.03 Million ≈ $3.12 Million |
-56.64% |
| 2010-12-31 | Skr66.95 Million ≈ $7.20 Million |
-20.89% |
| 2009-12-31 | Skr84.63 Million ≈ $9.11 Million |
-20.55% |
| 2008-12-31 | Skr106.52 Million ≈ $11.46 Million |
-34.66% |
| 2007-12-31 | Skr163.02 Million ≈ $17.54 Million |
-27.88% |
| 2006-12-31 | Skr226.03 Million ≈ $24.32 Million |
-1.61% |
| 2005-12-31 | Skr229.72 Million ≈ $24.72 Million |
+2.34% |
| 2004-12-31 | Skr224.47 Million ≈ $24.16 Million |
-0.27% |
| 2003-12-31 | Skr225.09 Million ≈ $24.22 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Ortivus AB ser. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | Skr22.41 Million | 100.00% |
| Total Equity | Skr22.41 Million | 100.00% |
Ortivus AB ser. A Competitors by Market Cap
The table below lists competitors of Ortivus AB ser. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mitra Komunikasi Nusantara Tbk PT
JK:MKNT
|
$322.28K |
|
Inspiration Healthcare Group PLC
LSE:IHC
|
$322.92K |
|
Dewhurst plc
LSE:DWHA
|
$323.07K |
|
SRAX Inc
NASDAQ:SRAX
|
$323.82K |
|
Checkit PLC
LSE:CKT
|
$321.97K |
|
Desarrolladora Homex S.A.B. de C.V
MX:HOMEX
|
$320.51K |
|
GO.D.M Investments Ltd
TA:GODM
|
$319.94K |
|
Works co uk PLC
LSE:WRKS
|
$319.67K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ortivus AB ser. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -7,165,000 to 22,414,000, a change of 29,579,000.
- Net loss of 21,876,000 reduced equity.
- Other comprehensive income decreased equity by 1,246,000.
- Other factors increased equity by 52,701,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-21.88 Million | -97.6% |
| Other Comprehensive Income | Skr-1.25 Million | -5.56% |
| Other Changes | Skr52.70 Million | +235.13% |
| Total Change | Skr- | % |
Book Value vs Market Value Analysis
This analysis compares Ortivus AB ser. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.13x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.18x to 4.13x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | Skr10.28 | Skr1.80 | x |
| 2004-12-31 | Skr10.25 | Skr1.80 | x |
| 2005-12-31 | Skr10.49 | Skr1.80 | x |
| 2006-12-31 | Skr8.13 | Skr1.80 | x |
| 2007-12-31 | Skr4.86 | Skr1.80 | x |
| 2008-12-31 | Skr3.21 | Skr1.80 | x |
| 2009-12-31 | Skr2.58 | Skr1.80 | x |
| 2010-12-31 | Skr2.04 | Skr1.80 | x |
| 2011-12-31 | Skr0.88 | Skr1.80 | x |
| 2012-12-31 | Skr0.95 | Skr1.80 | x |
| 2013-12-31 | Skr0.52 | Skr1.80 | x |
| 2014-12-31 | Skr0.59 | Skr1.80 | x |
| 2015-12-31 | Skr0.38 | Skr1.80 | x |
| 2016-12-31 | Skr0.21 | Skr1.80 | x |
| 2017-12-31 | Skr0.52 | Skr1.80 | x |
| 2018-12-31 | Skr0.07 | Skr1.80 | x |
| 2019-12-31 | Skr0.23 | Skr1.80 | x |
| 2020-12-31 | Skr0.44 | Skr1.80 | x |
| 2021-12-31 | Skr0.66 | Skr1.80 | x |
| 2022-12-31 | Skr0.80 | Skr1.80 | x |
| 2023-12-31 | Skr0.39 | Skr1.80 | x |
| 2024-12-31 | Skr-0.16 | Skr1.80 | x |
| 2025-12-31 | Skr0.44 | Skr1.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ortivus AB ser. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -97.60%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -29.80%
- • Asset Turnover: 1.03x
- • Equity Multiplier: 3.16x
- Recent ROE (-97.60%) is below the historical average (-68.76%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 3.41% | 4.38% | 0.67x | 1.17x | Skr-14.83 Million |
| 2004 | 5.79% | 9.23% | 0.54x | 1.15x | Skr-9.45 Million |
| 2005 | -7.71% | -10.21% | 0.49x | 1.55x | Skr-40.68 Million |
| 2006 | -66.00% | -74.68% | 0.60x | 1.48x | Skr-171.79 Million |
| 2007 | -37.60% | -37.74% | 0.64x | 1.55x | Skr-77.59 Million |
| 2008 | -64.73% | -82.95% | 0.46x | 1.70x | Skr-79.60 Million |
| 2009 | -21.84% | -17.59% | 0.64x | 1.94x | Skr-26.94 Million |
| 2010 | -33.27% | -46.66% | 0.57x | 1.25x | Skr-28.97 Million |
| 2011 | -130.41% | -82.76% | 0.90x | 1.76x | Skr-40.76 Million |
| 2012 | 7.12% | 3.66% | 1.14x | 1.71x | Skr-898.70K |
| 2013 | -81.59% | -38.89% | 0.98x | 2.14x | Skr-15.76 Million |
| 2014 | 7.24% | 2.02% | 0.84x | 4.28x | Skr-534.70K |
| 2015 | -57.35% | -9.76% | 1.10x | 5.34x | Skr-8.33 Million |
| 2016 | -135.56% | -9.53% | 1.57x | 9.05x | Skr-7.60 Million |
| 2017 | -74.61% | -19.74% | 1.70x | 2.22x | Skr-13.16 Million |
| 2018 | -613.98% | -25.65% | 1.88x | 12.70x | Skr-13.61 Million |
| 2019 | -182.84% | -31.48% | 1.46x | 3.99x | Skr-16.88 Million |
| 2020 | 57.59% | 10.53% | 1.62x | 3.38x | Skr9.36 Million |
| 2021 | 31.28% | 9.77% | 1.30x | 2.46x | Skr6.27 Million |
| 2022 | 16.63% | 5.64% | 1.16x | 2.53x | Skr2.35 Million |
| 2023 | -105.43% | -21.70% | 1.16x | 4.20x | Skr-19.98 Million |
| 2024 | 0.00% | -30.97% | 1.26x | 0.00x | Skr-24.19 Million |
| 2025 | -97.60% | -29.80% | 1.03x | 3.16x | Skr-24.12 Million |
Industry Comparison
This section compares Ortivus AB ser. A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $291,257,889
- Average return on equity (ROE) among peers: -41.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ortivus AB ser. A (ORTI-A) | Skr22.41 Million | 3.41% | 2.16x | $322.08K |
| ADDvise Group AB A (ADDV-A) | $3.30 Million | 33.40% | 2.57x | $4.23 Million |
| ADDvise Group B (ADDV-B) | $835.00 Million | 10.78% | 3.13x | $108.58 Million |
| AddLife AB (publ) (ALIF-B) | $346.60 Million | 22.45% | 2.68x | $1.80 Billion |
| Biotage AB (BIOT) | $990.04 Million | 17.68% | 0.45x | $1.23 Billion |
| Bonesupport Holding AB (BONEX) | $34.30 Million | -321.22% | 4.50x | $1.56 Billion |
| Dynavox Group (DYVOX) | $139.50 Million | 21.36% | 7.22x | $930.88 Million |
| iZafe Group AB Series B (IZAFE-B) | $40.73 Million | -89.06% | 0.19x | $14.83 Million |
| Ortivus AB ser. B (ORTI-B) | $224.47 Million | 5.79% | 0.15x | $14.04 Million |
| S2Medical AB (S2M) | $7.38 Million | -72.91% | 0.51x | $611.88K |
About Ortivus AB ser. A
Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMe… Read more